Yoshiharu Morimoto

Yoshiharu Morimoto


Yoshiharu Morimoto M.D., Ph.D. is an internationally recognized clinician, researcher, educator and pioneer in the field of reproductive medicine and biology. He is the CEO of IVF Japan Group consisted of 3 clinics: HORAC Grand Front Osaka Clinic, IVF Osaka Clinic, and IVF Namba Clinic.

He started to offer and spread a new idea of integrated medical method to the world and his cutting-edge technology “AUGMENT (Autologous Germline Mitochondrial Energy Transfer)” has been introduced for intractable patients. These active scientific works have enabled him to treat more than 2 million patients so far with a high pregnancy success rate.

Major service to societies:

  • President, International Society for In Vitro Fertilization (ISIVF).
  • Past President, Pacific Society for Reproductive Medicine (PSRM).
  • Past President, Asia Pacific Initiative on Reproduction (ASPIRE), the editorial board member of the official Journal “Fertility and Reproduction”.